Search results
Alpha-1 Wrestling’s Return Announced For February 2024
Wrestle Zone via Yahoo News· 7 months agoAlpha-1 Wrestling is returning in 2024. In a video on his YouTube channel, Ethan Page announced that...
Ethan Page Announces More Details On The Return Of Alpha-1 Wrestling
Wrestle Zone via Yahoo News· 7 months agoEthan Page has revealed more information on the upcoming return of his independent promotion Alpha-1...
Ethan Page Reveals One Of The Favorite Things He’s Ever Done In His Career
Wrestle Zone via Yahoo News· 5 months agoEthan Page is really excited about relaunching Alpha-1 Wrestling in 2024. All Elite Wrestling’s...
Nothing Phone (1) gets the first taste of Android 13 via Paranoid Android
Android Central via Yahoo News· 2 years agoNothing Phone (1) next to a neon glowing number 13 What you need to know Nothing Phone (1) gets a...
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
Benzinga via Yahoo Finance· 2 years agoVertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1...
Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
Investor's Business Daily· 5 months agoSanofi is getting into the liver disease treatment space with its $1.7 billion acquisition of...
Sanofi to buy Inhibrx in deal worth up to $2.2B
BioPharma Dive via Yahoo Finance· 5 months agoThe acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun into a new...
A new non-surgical procedure is helping those with emphysema breathe better. The only problem? Not...
USA TODAY via Yahoo News· 2 years agoMILWAUKEE — About two years ago, John McLees' lungs had become so badly damaged that he could barely...
Scott Kenyon, Agent at Innovative Artists, Dies at 39
The Wrap via Yahoo News· 3 months ago“He has become a brother, son, and mentor to all of us at Innovative,” agency VP Maury DiMauro said...
Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
Investor's Business Daily· 2 years agoArrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...